Supplements With Evidence In Mild Cognitive Impairment
Quick Read Mild cognitive impairment is a grey zone between normal age-related memory changes and dementia, and it may be
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
Depression and dementia are linked through shared biological damage in the brain. Depression triggers a stress response that floods the brain with cortisol, causing brain shrinkage and inflammation, while weakening the brain’s ability to repair itself. Research tracking nearly 100,000 people over 14 years found that each episode of depression raised dementia risk by roughly 25 to 28 percent. What matters most is not just whether you have depression, but how it changes over time. Depression that gets worse, emerges in your 50s or 60s, or stays active for years carries significantly higher risk than stable mild symptoms.
Cognitive decline can actually begin before depression appears, suggesting the two conditions may be feeding each other. Studies show that active, untreated depression within the past two years raises cognitive decline risk by 41 percent, even in people with a depression history. The evidence for treating depression as a brain health issue, not just a mood issue, is now substantial enough to change how people think about managing it in midlife and beyond.
Regular physical exercise appears to be the most promising tool for addressing both conditions simultaneously, as it counteracts the shared biological damage by reducing stress hormones, promoting new brain cell growth, and reducing inflammation. The research does not yet definitively prove that treating depression prevents dementia, and one large UK study found no link, so questions remain about causality and individual variation.
Verdict: Depression, particularly when worsening or persistent in midlife, is a significant and modifiable dementia risk factor that deserves urgent attention and active management.
Most of us think about depression and dementia as two separate problems. Depression is a mood disorder, something that happens in your emotional life. Dementia is a brain disease, something that happens to your memory. We treat them differently, we talk about them differently, and for decades, medicine kept them in separate boxes.
But what if that separation has been costing us something important?
A growing body of research now suggests that depression and dementia aren’t just conditions that happen to co-occur in older adults, they may share deep biological roots, feed each other in a dangerous cycle, and together accelerate the very brain changes that lead to cognitive decline. More strikingly, the *way* depression unfolds over your lifetime, whether it’s persistent, worsening, or repeatedly recurring, may matter as much as whether you’ve experienced it at all. Vitacuity analysed over 1.77 million research papers to bring you the most relevant findings on this relationship. What we found is both sobering and, critically, actionable.
To understand why depression might raise dementia risk, you need to understand what depression actually *does* to the brain, beyond the emotional experience of it.
Depression is not simply a shortage of serotonin. That’s an oversimplification that research has long moved past. What we now know is that depression involves a cascade of biological changes that, sustained over time, can cause measurable structural damage to the brain [1].
Here are the four main pathways that researchers believe link depression to dementia:
1. The stress hormone system goes haywire. Depression dysregulates what’s called the hypothalamic-pituitary-adrenal (HPA) axis, the system that governs your body’s stress response. When this system is chronically overactive, it floods the brain with cortisol. Sustained high cortisol damages neurons, particularly in the hippocampus, the brain region most critical for forming new memories, and the first to deteriorate in Alzheimer’s disease [1] [2].
2. The brain shrinks. Research has linked depression to measurable atrophy, actual shrinkage, in the hippocampus and prefrontal cortex. These are not peripheral brain areas. They are the architecture of memory, decision-making and executive function. When depression and dementia share these same zones of damage, it becomes harder to tell where one ends and the other begins [2].
3. Neuroinflammation smoulders. Chronic, low-grade inflammation in the brain is increasingly recognised as a mechanism in both depression and neurodegeneration. In depression, pro-inflammatory signals (cytokines) appear to cross the blood-brain barrier, interfere with neurotransmitter function and accelerate the kind of cellular damage associated with Alzheimer’s pathology [1] [2].
4. Neuroplasticity breaks down. Healthy brains continuously form new connections and even new neurons, a process called neuroplasticity. Depression appears to suppress this process, reducing the brain’s ability to repair itself and adapt to damage [1]. This is the biological opposite of what you want if you’re trying to build cognitive resilience.
What makes this particularly important is that these pathways are *modifiable*. They’re not fixed genetic destiny. They are biological processes that respond to interventions, which is why understanding them is the first step toward doing something about them.
Evidence grade: Strong, multiple large cohort studies and meta-analyses involving hundreds of thousands of participants
Let’s get specific, because the numbers in the research are genuinely important.
A major 2025 study using UK Biobank data, 97,157 participants with a 14-year follow-up, found that each additional period of depression was associated with a 28% increased risk of all-cause dementia (hazard ratio 1.28) and a 25% increased risk of Alzheimer’s specifically (HR 1.25) [4]. This was not a small sample over a few years. This was nearly 100,000 people tracked for over a decade.
A separate analysis published in Alzheimer’s & Dementia (2025) pooled data from 23,305 adults across four major international cohort studies, ELSA (UK), HRS (USA), SHARE (Europe), and CHARLS (China), with a median follow-up of nearly 11 years. Every single point increase in cumulative depression score was associated with a 3-8% higher dementia hazard. But here’s the figure that should stop you in your tracks: those in the *highest* quartile of sustained depressive symptoms had up to 18 times the dementia hazard of those in the lowest quartile in one of the cohorts [13].
Sustained high symptoms for four years or more was associated with approximately 2.7 to 3.9 times greater dementia risk [13].
These are not marginal numbers. They represent a substantial, dose-dependent relationship between the burden of depression and the risk of losing your cognitive future.
Evidence grade: Strong, multiple large longitudinal cohorts, meta-analysis of 16 studies
One of the most important recent insights in this research area is that a single snapshot of whether someone is depressed is a poor predictor of dementia risk. What matters is the *trajectory*, how depression unfolds over time.
The UK Biobank and ADNI study (2026) [4] meta-analysed data from 16 longitudinal cohorts and identified six distinct depression trajectories that each predicted elevated dementia risk:
– Stable mild symptoms: 43% elevated risk – Stable high symptoms: 74% elevated risk – Increasing symptoms: 68% elevated risk – Adult-onset depression: 38% elevated risk – Mid-to-late life depression: 84% elevated risk, the highest of any trajectory – Lifelong depression: 33% elevated risk
The finding about *mid-to-late life depression* carrying the highest risk is particularly relevant to our audience. Depression that first emerges, or worsens, in your 50s and 60s appears to carry especially serious implications for brain health [4].
Also notable: in the ADNI cohort, it was *increasing* depressive symptoms (not stable mild ones) that drove the elevated risk. An HR of 2.33 was found for those on a worsening trajectory compared to those consistently symptom-free [4]. In other words, it’s not just *having* low-level depression that matters, it’s depression that is getting *worse* that raises the alarm most loudly.
The message from the data is clear: this is not a condition to leave unmanaged and unmonitored.
Evidence grade: Strong, three large international prospective cohorts, 40,167 participants
One of the more unsettling findings in this literature is what happens *before* depression is even diagnosed.
A 2026 cohort study [5] analysed 40,167 older adults from CHARLS, HRS and SHARE, tracking over 401,000 person-years. The finding: cognitive decline doesn’t just follow depression, it actually precedes it. Those who later developed depression were already showing faster-than-normal cognitive deterioration *before* their depression onset, and then showed acute decline at the point of onset, followed by further accelerated decline afterwards.
This plays out across memory, executive function and orientation, not just one cognitive domain [5].
This tells us something important: by the time depression and cognitive decline are both visible, the brain has often already been under pressure for some time. Waiting for obvious symptoms before acting means you’ve already lost ground.
Evidence grade: Promising, large observational dataset, though not randomised
A 2018 study from the National Alzheimer’s Coordinating Center [9] followed 2,655 older adults who had a history of depression and normal cognition at baseline, tracking them for a median of nearly 42 months. By the end, 22.1% had developed either mild cognitive impairment (MCI) or dementia.
After adjusting for all confounders, *active depression within the last two years* was one of only a handful of variables that remained independently and significantly associated with cognitive decline, with a hazard ratio of 1.41 (a 41% increased risk) [9]. Increased severity of depression also independently predicted risk (HR 1.05 per unit of severity).
Critically, this was in people who *already had a depression history*. The implication is stark: it’s not enough to have experienced depression and recovered. Whether your depression is *currently active*, whether it is being managed or left to run, is itself a meaningful predictor of your cognitive trajectory.
Evidence grade: Promising, mechanistic reviews with supporting human data, not yet sufficient RCT evidence for definitive claims
Given that depression and dementia share so many biological pathways, a logical question is: is there a single intervention that targets both simultaneously?
Two 2025 reviews [2] [8] converge on physical exercise as the most promising non-pharmacological candidate. The reasoning is mechanistic and coherent: exercise has been shown to directly counteract several of the shared pathological processes:
– It modulates HPA axis dysfunction, reducing chronic cortisol dysregulation – It promotes hippocampal neurogenesis, literally growing new brain cells in the region most vulnerable to both depression and dementia – It reduces neuroinflammation – It counteracts brain atrophy in both the hippocampus and prefrontal cortex
The reviews also highlight what researchers call “muscle-brain crosstalk”, the idea that contracting muscles release chemical signals (including a protein called BDNF, brain-derived neurotrophic factor) that directly support neuroplasticity and mood regulation [2] [8].
The honest caveat here is that most of the mechanistic evidence comes from animal studies and observational data in humans. We don’t yet have large, long-duration RCTs showing definitively that exercise *prevents* dementia in people with depression. But the convergence of biological plausibility, mechanistic evidence and observational data is compelling, and the risk-benefit ratio of regular moderate exercise is essentially zero.
Science is most trustworthy when it’s honest about its own limits. Here’s what the research hasn’t resolved.
The causality question remains genuinely open. A 2025 paper [12] systematically applied causal criteria (the Bradford Hill criteria) to the depression-dementia relationship and found that while the evidence is consistent and biologically coherent, the *relative contributions* of a true causal relationship, reverse causality, and confounding factors remain unclear. It is possible that depression causes dementia pathology. It is also possible that early, undetected neurodegeneration *causes* depression, meaning depression is sometimes a symptom of impending dementia rather than a cause of it. It is probably both, operating as a bidirectional cycle [1] [3].
Not all studies agree. The Whitehall II cohort study (2023) [10], a well-conducted UK longitudinal study with 15-year follow-up, found that depression in people over 50 was *not* associated with increased cognitive decline in episodic memory, verbal fluency or abstract reasoning, after controlling for confounders. This stands in contrast to the larger body of literature. The researchers noted that depressed individuals performed worse *cross-sectionally* (at a single point in time) but didn’t deteriorate faster over the follow-up period. The discrepancy may reflect differences in how depression was defined and measured, the specific cognitive tests used, or genuine population-level variation. This is a real conflict in the literature, not something to paper over, though the overwhelming weight of large-scale cohort evidence and meta-analyses does point toward depression as a meaningful risk factor [4] [13].
We don’t know whether treating depression reduces dementia risk. This is the crucial gap. Depression is consistently associated with higher dementia risk. Active, unmanaged depression carries the highest risk [9]. But we don’t yet have robust randomised controlled trial evidence showing that successfully treating depression reduces dementia incidence. The research on antidepressants is particularly complex: some studies suggest neuroprotective benefits (reduced amyloid burden, promoted neurogenesis), while others raise concerns that antidepressant use might paradoxically be associated with higher dementia risk, possibly because they are being used in patients who already have early undetected neurodegeneration [7]. This is an area that urgently needs better-designed research.
Individual variation is enormous. The same level of depressive symptoms carries different risk depending on when in life they occur, how long they persist, whether they fluctuate, and, presumably, an individual’s underlying genetic and biological context. We are not yet at the point where we can tell an individual precisely how their personal depression history translates to their personal dementia risk.
Let’s step back and think about what a sensible, informed person should actually *do* with this information.
The research, drawn from studies involving hundreds of thousands of people across multiple continents and tracked over more than a decade, tells a consistent story: depression, particularly when it is persistent, worsening, or recurring across mid-to-late life, is one of the most significant potentially modifiable risk factors for dementia that we know of.
This is not a reason for alarm. It is a reason for *attention*.
Here is what the evidence supports, practically:
1. Take depression seriously as a brain health issue, not just a mental health one. If you have a history of depression, this isn’t just about how you feel day-to-day. The evidence suggests it has implications for your cognitive future. That reframes the urgency of managing it well.
2. Monitor the *pattern*, not just the presence. What the latest research makes clear is that trajectory matters. Worsening symptoms, recurring episodes, and sustained high-symptom periods carry the greatest risk [4] [13]. If you notice your mood getting worse over months, not better, that’s worth acting on specifically because of what the data shows about escalating trajectories.
3. Don’t leave depression untreated and assume it will pass. Active depression in the previous two years was independently associated with a 41% higher risk of cognitive decline in the National Alzheimer’s Coordinating Center study [9]. Whether you manage it through therapy, medication, lifestyle, or a combination, leaving it unmanaged appears to carry a real cost.
4. Move your body, consistently. The evidence for exercise targeting the shared biological pathways of both depression and dementia is genuinely compelling [2] [8]. You don’t need a sophisticated protocol. Regular aerobic exercise, walking briskly, cycling, swimming, three to five times a week, at a level that makes you slightly breathless, engages the muscle-brain signalling pathways that support hippocampal health and mood regulation. It is free, accessible, and the evidence base for it is growing steadily.
5. Understand that cognitive changes can precede depression. If you’re noticing subtle cognitive slowing, word-finding difficulties, slower processing, alongside low mood, the 2026 cohort data [5] suggests these may already be reflecting a shared biological process. Both deserve attention simultaneously, not sequentially.
6. Be honest with your GP about mood. It can feel easier to focus on physical health at appointments. But if you’re in your 40s, 50s or 60s and experiencing persistent low mood, there is now strong, large-scale evidence that this is directly relevant to your brain health trajectory, not separate from it.
The research here is not perfect. The causal questions aren’t fully resolved. But when multiple large datasets, tracking hundreds of thousands of people across a decade, consistently point in the same direction, the sensible, informed response is not to wait for certainty. It is to act on what the evidence most strongly suggests, while remaining open to learning more.
Managing your mental health in midlife and beyond isn’t just about feeling better now. Based on the weight of current evidence, it may be one of the most important things you can do for the brain you want to have in your 70s, 80s and beyond.
[1] Neurobiological and therapeutic landmarks of depression associated with Alzheimer’s disease dementia (2025). *Frontiers in Aging Neuroscience*. DOI: 10.3389/fnagi.2025.1584607 | https://pubmed.ncbi.nlm.nih.gov/40529210/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171374/
[2] Shared Mechanisms in Dementia and Depression: The Modulatory Role of Physical Exercise (2025). *Journal of Neurochemistry*. DOI: 10.1111/jnc.70185 | https://pubmed.ncbi.nlm.nih.gov/40757845/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320575/
[3] Is this a Gordian knot? Disentangling the relationship between depression and dementia (2025). https://pubmed.ncbi.nlm.nih.gov/40316441/
[4] Dynamic characteristics of depressive symptoms and risk of all-cause dementia and Alzheimer’s disease: Two population-based cohorts and evidence synthesis of longitudinal studies (2026). *Journal of Affective Disorders*. DOI: 10.1016/j.jad.2025.120646 | https://pubmed.ncbi.nlm.nih.gov/41224007/
[5] Cognitive decline before and after incident depression: Evidence from three international prospective cohorts (2026). *Archives of Gerontology and Geriatrics*. DOI: 10.1016/j.archger.2025.106086 | https://pubmed.ncbi.nlm.nih.gov/41275705/
[7] Exploring the Complex Relationship Between Antidepressants, Depression and Neurocognitive Disorders (2024). https://pubmed.ncbi.nlm.nih.gov/39767653/
[8] Shared Mechanisms in Dementia and Depression: The Modulatory Role of Physical Exercise (2025). *Journal of Neurochemistry*. DOI: 10.1111/jnc.70185 | https://pubmed.ncbi.nlm.nih.gov/40757845/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320575/
[9] Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors (2018). *Journal of Clinical Psychiatry*. DOI: 10.4088/JCP.18m12331 | https://pubmed.ncbi.nlm.nih.gov/30549490/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296258/
[10] Does depression in mid-life predispose to greater cognitive decline in later life in the Whitehall II cohort? (2023). *Journal of Affective Disorders*. DOI: 10.1016/j.jad.2023.05.014 | https://pubmed.ncbi.nlm.nih.gov/37172658/
[12] Depression and dementia: interrogating the causality of the relationship (2025). https://pubmed.ncbi.nlm.nih.gov/39798961/
[13] Cumulative and variable depression symptom exposure and incident dementia: Panel data analysis of four longitudinal cohort studies (2025). *Alzheimer’s & Dementia*. DOI: 10.1002/alz.70950 | https://pubmed.ncbi.nlm.nih.gov/41313677/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12662180/
[15] Temporal dynamics in the association between depression and dementia: an umbrella review and meta-analysis (2025). https://pubmed.ncbi.nlm.nih.gov/40687743/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Mild cognitive impairment is a grey zone between normal age-related memory changes and dementia, and it may be
Quick Read Your brain has a nightly cleaning system called the glymphatic system that removes toxic waste proteins during deep
